Drs. Weaver & Albers

Drs. Weaver & Albers Medical clinic A family medical clinic located in the Audubon Park district of Orlando dedicated to delivering the highest quality healthcare to the community.

We are committed to providing state of the art care in a warm, safe and comfortable environment. We pride ourselves on the core values that guide us in our patient care; integrity, honesty and compassion. We invite you to visit our website to learn more about us and if we may be of service for your healthcare needs.

Please be advised that we are having staffing shortages and may be delayed in returning your calls. We are working dilig...
11/17/2021

Please be advised that we are having staffing shortages and may be delayed in returning your calls. We are working diligently to respond to your inquiries but please bare with us in these challenging times

Dr’s W & A

04/04/2020

Starting Monday, April 7, we will have the ability to fully test for Covid 19 (Novel Coronavirus) for all patients. If you feel you have the symptoms suggestive of Covid 19 such as dry cough, fever, shortness of breath or have been exposed to someone who has tested positive to the coronavirus please contact the office. We also now offer telehealth for those individuals who are unable or unwilling to travel to the office to be seen. For everyone, Stay Healthy and Be Well!!

03/28/2018

SCREENING COLONOSCOPY
SUMMARY AND RECOMMENDATIONS

●Colonoscopy includes visualization of the re**um, colon, and the distal portion of terminal ileum, with real-time assessment and interpretation of the findings encountered.

●Colonoscopy is indicated for the diagnostic evaluation of signs and symptoms of a wide variety of gastrointestinal disorders, for colon cancer screening, and for therapeutic interventions

●Preparation for colonoscopy typically involves the ingestion of a low-residue diet or clear liquids for at least one day prior to the examination, combined with an oral gastrointestinal lavage. Most medications may be continued up to the time of colonoscopy, but management of antiplatelet agents and anticoagulants must take into account the procedure-related risk of bleeding and the risk of thrombosis. Antibiotic prophylaxis is not required for patients undergoing colonoscopy.

●Routine colonoscopy is performed using a high-definition white-light colonoscope. Multiple accessories are available to aid with diagnostic and therapeutic maneuvers. In addition, options are available to enhance visualization during colonoscopy (eg, chromoendoscopy), although many require specialized equipment and training.

●A variety of diagnostic and therapeutic maneuvers can be performed during colonoscopy. The most common maneuver is tissue sampling, including routine polypectomy.

Other interventions include:

•Endoscopic hemostasis

•Dilation of colonic strictures

•Stent placement for malignant disease

•Endoscopic mucosal resection and endoscopic submucosal dissection of large colonic polyps

•Colonic decompression tube placement

•Percutaneous endoscopic cecostomy tube placement

•Foreign body removal

●Serious complications of colonoscopy are rare (approximately 3 per 1000 screening colonoscopies) and include complications of sedation, complications related to the preparation, bleeding, and perforation.

●Bleeding is usually associated with polypectomy and rarely accompanies diagnostic colonoscopy. Postpolypectomy bleeding occurs in approximately 1 to 2 percent of polypectomies, with higher rates seen with the removal of larger polyps. Patients may present with hematochezia or melena days to weeks after the colonoscopy. The majority of patients can be managed with a repeat colonoscopy to both identify and treat the source of bleeding.

●Perforation rates vary with the procedure being performed, with rates of 0.01 to 0.1 percent for screening colonoscopy. The most common symptom of a colonic perforation is abdominal pain. Other symptoms include fever, nausea, vomiting, dyspnea, chest pain, scapular pain, and neck pain. However, patients with retroperitoneal perforations may have minimal or atypical symptoms. The physical examination may be notable for diffuse or localized abdominal tenderness with peritoneal signs.

If perforation is suspected, immediate abdominal radiographs (plain and upright or lateral decubitus) and an upright chest radiograph should be obtained. If plain films are normal but there is a high suspicion of perforation, an abdominopelvic computed tomography scan with water-soluble contrast should be obtained. All patients with perforations should receive intravenous fluids and broad spectrum antibiotics. Many patients with perforations will require surgery, though nonsurgical management may be possible in those with small perforations without evidence of peritonitis.

10/27/2017

FDA Approves New Shingles Vaccine

On October 23rd the FDA approved a new shingles vaccine for adults over the age of 50. This vaccine, known as Shingrix, is recommended to replace the current vaccine, Zostavax, which is approved for adults over the age of 60. If you have already received the previous Zostavax vaccine it is recommended that you also receive the new vaccine. Shingrix involves one series of two injections 30 days apart. Supplies of the new vaccine should be available for distribution within 45 days of this notice.

If you have any questions please don't hesitate to contact the office either through the patient portal or call us at 407-395-4707.

09/27/2017

Patient information on prevention of pneumonia from Up to Date (medical research aggregator)

The most commonly identified cause of pneumonia leading to hospitalization in the United States is the bacterium Streptococcus pneumoniae, also called pneumococcus. Pneumococcal vaccine is the best way to prevent infection with pneumococcus. Vaccination reduces the number of cases that occur and makes disease less severe when it does occur. Influenza vaccine can also help to prevent pneumococcal pneumonia or pneumonia caused by other bacteria, which can happen as a complication of the flu. (See "Patient education: Influenza prevention (Beyond the Basics)".)

This topic discusses the potential benefits of the pneumococcal vaccines and who should receive them. Symptoms and treatment of pneumonia are discussed separately. (See "Patient education: Pneumonia in adults (Beyond the Basics)".)

PNEUMONIA VACCINE

There are many different types of pneumococci. Pneumococcal vaccines protect against the most common types by reducing the number of cases that occur and also by reducing the severity of infection when it does occur.

Kinds of pneumococcal vaccines — Two kinds of pneumococcal vaccine are available in the United States, PPSV23 (pneumococcal polysaccharide vaccine 23), which protects against 23 pneumococcal types, and PCV13 (pneumococcal conjugate vaccine 13), which protects against only 13 of these types but may be preferable to PPSV23 in some individuals:

●PPSV23 is recommended for all people over age 2 years who are at increased risk for pneumonia and for everyone 65 years old or older.

●PCV13 is recommended for all infants, for young children who missed receiving it earlier in life, and for adults with a weakened immune system or certain other risk factors for pneumonia, including being 65 years of age or older. (See "Patient education: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)".)

Who needs vaccination? — Vaccination needs vary by age and other factors (table 1):

Adults with any of the following risk factors should receive both PCV13 and PPSV23:

●Age 65 years or older

●Cerebrospinal fluid leak

●Cochlear implant

●Poor function of the spleen (which includes surgical removal of the spleen, sickle cell disease, or another hemoglobin disorder that damages the spleen)

●HIV infection

●Chronic kidney failure

●Nephrotic syndrome

●Leukemia

●Lymphoma, including Hodgkin disease

●Multiple myeloma

●Metastatic (generalized) cancer

●Organ transplantation

●Drugs that suppress immunity (including prednisone or other glucocorticoids)

●All immunodeficiency states

For the people described above who need both PCV13 and PPSV23, the timing of the two vaccines depends on age, risk factors, and prior vaccination (table 2). When possible, PCV13 should be given first, followed by PPSV23.

Adults aged 19 to 64 years who are cigarette smokers or who have one of the following conditions should receive PPSV23 alone:

●Diabetes mellitus

●Chronic heart disease, such as congestive heart failure or cardiomyopathy (an enlarged heart), but not just high blood pressure

●Chronic lung disease

●Alcoholism

●Chronic liver disease or cirrhosis of the liver

Anyone who develops pneumococcal pneumonia and who has not been vaccinated previously should be vaccinated with PPSV23; infection with one strain of pneumococcus does not protect against infection with other strains.

Who needs revaccination? — Adults over 65 years who received PPSV23 before age 65 should receive a one-time revaccination with PPSV23 at least five years after their previous dose of the vaccine.

Adults age 19 to 64 who have previously received PPSV23 alone or at least eight weeks after vaccination with PCV13 for certain conditions (eg, immunocompromise, lack of spleen) should receive a single revaccination with PPSV23 at least five years after the initial vaccination with PPSV23.

Revaccination with PCV13 is not recommended.

Both pneumococcal vaccines are safe to have during pregnancy.

Other vaccines — Yearly vaccination against influenza (the influenza vaccine or the "flu shot" or "flu vaccine") is recommended for all people who are at least six months of age. This vaccine is especially important for those who are at high risk for pneumonia because pneumonia is the most common serious complication of the flu.

The flu vaccine changes from year to year and is most likely to protect you if you get it as soon as it becomes available (usually by October in the northern hemisphere and May in the southern hemisphere). Nevertheless, it can still protect you if you get it later in the season and at any time during the influenza season (usually between October and April in the United States). (See "Patient education: Influenza prevention (Beyond the Basics)".)

Benefits — The pneumococcal vaccine prevents many cases of pneumonia and lessens the severity of pneumonia when it does occur. Likewise, the flu vaccine prevents many cases of influenza and lessens the severity of disease when it does occur. The flu vaccine also reduces the frequency of all bacterial pneumonias, including those caused by various types of bacteria, such as pneumococcus, Staphylococcus, and streptococci. Getting the flu vaccine each year and being up to date in recommendations for pneumococcal vaccine will not prevent all pneumonias but will provide the best known protection. If you are at high risk for either pneumonia or influenza, ask your healthcare provider about the benefits of vaccination for you.

INFECTION CONTROL

Influenza is a highly contagious disease, whereas the spread of pneumococcus is far less likely and less predictable. Infection control measures can help to prevent the spread of any type of infection, including pneumonia. Infection control is most commonly practiced in healthcare settings but is useful in the community as well. Frequent hand washing with soap and water or alcohol-based hand rubs can be effective, especially after contact with toddlers or young children who appear to have respiratory infections.

Because pneumonia is spread by contact with infected respiratory secretions, people with pneumonia should limit face-to-face contact with uninfected family and friends. They should also cover their mouth and nose when coughing or sneezing, and dispose of tissues immediately. Sneezing or coughing into the sleeve of one's clothing (at the inner elbow) is another means of containing sprays of saliva and secretions and has the advantage of not contaminating the hands.

WHERE TO GET MORE INFORMATION

Your healthcare provider is the best source of information for questions and concerns related to your medical problem.

09/17/2017

The office will be operating normal business hours starting at 7 am tomorrow. You have three ways to setup an appointment. You can call 407-395-4707, you can stop by the office and speak to the staff directly or you can request a date and time through the patient portal. If you are not on the portal contact the staff by phone and we can give you the instructions for signing up.

Drs Weaver & Albers

09/14/2017

These are the new guideline recommendations for influenza vaccination for the upcoming 2017-18 flu season. In summary we are recommending early vaccination with a non-live vaccine to the following groups

1) all children aged 6 through 59 months;
2) all persons aged ≥50 years;
3) adults and children who have chronic pulmonary (including asthma) or cardiovascular (except isolated hypertension), renal, hepatic, neurologic, hematologic, or metabolic disorders (including diabetes melitus);
4) persons who are immunocompromised due to any cause (including immunosuppression caused by medications or by HIV infection);
5) women who are or will be pregnant during the influenza season;
6) children and adolescents (aged 6 months through 18 years) who are receiving aspirin- or salicylate-containing medications and who might be at risk for experiencing Reye syndrome after influenza virus infection;
7) residents of nursing homes and other long-term care facilities;
8) American Indians/Alaska Natives; and
9) persons who are extremely obese (BMI ≥40).

If you do not fall into one of the categories and would like to be vaccinated we encourage you to talk with your doctor.

If you have any questions please contact us.

Drs Weaver & Albers

The official Facebook profile for CDC's Morbidity and Mortality Weekly Report (MMWR). For more information about MMWR go to www.cdc.gov/mmwr. Disclaimer: Posted comments and images do not necessarily represent the views of CDC.

09/14/2017

We are back to work today. We now have phone and internet so we will be functioning at full strength. If we can assist you in anyway or if you have any healthcare issues give us a call.

Drs Weaver & Albers

09/13/2017

The office is currently functioning without internet or phone service. We will be open at 7 am tomorrow but it will be with limited support.

If you have any issues call the office and leave a voicemail and someone will get back to you.

Drs Weaver & Albers

Address

3120 Corrine Drive
Orlando, FL
32803

Opening Hours

Monday 7am - 3pm
Tuesday 7am - 3pm
Wednesday 7am - 3pm
Thursday 7am - 4pm
Friday 7am - 4pm

Telephone

+14073954707

Alerts

Be the first to know and let us send you an email when Drs. Weaver & Albers posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Drs. Weaver & Albers:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

A family medical clinic located in the Audubon Park district of Orlando dedicated to delivering the highest quality healthcare to the community. We are committed to providing state of the art care in a warm, safe and comfortable environment. We pride ourselves on the core values that guide us in our patient care; integrity, honesty and compassion. We invite you to visit our website to learn more about us and if we may be of service for your healthcare needs.